# Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

> **NCT00083304** · PHASE3 · COMPLETED · sponsor: **Spectrum Pharmaceuticals, Inc** · enrollment: 368 (actual)

## Conditions studied

- Breast Cancer
- Metastases

## Interventions

- **DRUG:** Efaproxiral
- **RADIATION:** Whole Brain Radiation Therapy (WBRT)
- **OTHER:** Supplemental Oxygen

## Key facts

- **NCT ID:** NCT00083304
- **Lead sponsor:** Spectrum Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083304, "Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00083304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*